NCT04725695 (LIDOGAS) is a Phase 4 clinical trial of Viscous Lidocaine in Anesthetics, Local, sponsored by Bispebjerg Hospital.

Who is sponsoring NCT04725695?

NCT04725695 is sponsored by Bispebjerg Hospital.

What drugs are being tested in NCT04725695?

Interventions in NCT04725695: Viscous Lidocaine.

What condition does NCT04725695 study?

NCT04725695 studies Anesthetics, Local, Esophagogastroduodenoscopy.

Is NCT04725695 still recruiting?

NCT04725695 is currently terminated. Last updated 6 February 2025.

Last reviewed 2025-02-06 · How we verify

NCT04725695: LIDOGAS

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Preoperative Viscous Lidocaine for Upper Gastrointestinal Endoscopy

Terminated Phase 4 Last updated 6 February 2025

What this trial tests

Phase 4 trial testing Viscous Lidocaine in Anesthetics, Local in 119 participants. Terminated before completion.

Timeline

29 March 2022

Primary endpoint
15 December 2023

30 October 2024

Quick facts

Lead sponsor	Bispebjerg Hospital
Phase	Phase 4
Status	Terminated
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	quadruple
Primary purpose	supportive care
Enrollment	119
Start date	29 March 2022
Primary completion	15 December 2023
Estimated completion	30 October 2024
Sites	1 location across Denmark

Drugs / interventions tested

Viscous Lidocaine — full drug profile →

Conditions studied

Anesthetics, Local — all drugs for Anesthetics, Local →
Esophagogastroduodenoscopy — all drugs for Esophagogastroduodenoscopy →

Sponsor

Bispebjerg Hospital

Who can join

Adults 18 to 75, any sex, with Anesthetics, Local or Esophagogastroduodenoscopy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In this randomized placebo-controlled clinical trial, patients will be randomized to be administered viscous lidocaine or placebo preoperatively to elective upper GI endoscopy

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Bispebjerg Hospital trials

Trials by the same sponsor.

NCT06872060 — The Effects of Glucagon on Renal Regional Blood Flow in Humans Measured by Magnetic Resonance. · NA · not yet recruiting
NCT07373587 — Preventing Hospital Associated Disability in Older Patients: Individualized Nutrition and Exercise Strategy · NA · not yet recruiting
NCT07123558 — Anal Cancer Prevention in High-Risk Categories of Men Who Have Sex With Men · NA · not yet recruiting
NCT07124338 — Preventing Hospital Associated Disability in Older Patients: Individualized Nutrition and Exercise Strategy, a Feasibili · NA · active not recruiting
NCT07096648 — Alert Burden When Monitoring Patients at Home · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04725695 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Bispebjerg Hospital
Last refreshed: 6 February 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04725695.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing